Truist Financial Corp Amneal Pharmaceuticals, Inc. Transaction History

Truist Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$3.36 - $6.21 $218,836 - $404,457	65,130 New	65,130 $395,000
Q3 2022 Oct 26, 2022	SELL	$2.02 - $3.62 $72,614 - $130,131	-35,948 Reduced 59.08%	24,896 $50,000
Q3 2021 Nov 05, 2021	SELL	$4.31 - $5.64 $62,671 - $82,011	-14,541 Reduced 19.29%	60,844 $325,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $385,971 - $514,125	75,385 New	75,385 $386,000
Q4 2020 Feb 18, 2021	SELL	$3.95 - $5.42 $39,500 - $54,200	-10,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $204 - $444	-83 Reduced 0.82%	10,000 $35,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $26,719 - $56,061	10,083 New	10,083 $49,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.